172 related articles for article (PubMed ID: 35478672)
1. Evaluation of Radiation Exposure to the Patients Undergoing Positron Emission Tomography/Computed Tomography-Guided Biopsies.
Deva K; Rana N; Kumar R; Mittal BR
Indian J Nucl Med; 2022; 37(1):23-28. PubMed ID: 35478672
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm.
Kumar R; Mittal BR; Bhattacharya A; Vadi SK; Singh H; Bal A; Shukla J; Singh H; Sharma V; Sood A; Singh SK
Diagn Interv Imaging; 2020 Mar; 101(3):157-167. PubMed ID: 31722844
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography.
Li L; Wan L; Zhao H; Wang C; Wei W; Liu J
Quant Imaging Med Surg; 2023 Aug; 13(8):5182-5194. PubMed ID: 37581077
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Radiation dosimetry of [
Sandgren K; Johansson L; Axelsson J; Jonsson J; Ögren M; Ögren M; Andersson M; Strandberg S; Nyholm T; Riklund K; Widmark A
EJNMMI Phys; 2019 Jan; 6(1):2. PubMed ID: 30631980
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.
Pfob CH; Ziegler S; Graner FP; Köhner M; Schachoff S; Blechert B; Wester HJ; Scheidhauer K; Schwaiger M; Maurer T; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1962-70. PubMed ID: 27207281
[TBL] [Abstract][Full Text] [Related]
7. Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing.
Afshar-Oromieh A; Hetzheim H; Kübler W; Kratochwil C; Giesel FL; Hope TA; Eder M; Eisenhut M; Kopka K; Haberkorn U
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1611-20. PubMed ID: 27260521
[TBL] [Abstract][Full Text] [Related]
8. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract][Full Text] [Related]
9. Radiation Exposure to the Personnel Performing Robotic Arm-Assisted Positron Emission Tomography/Computed Tomography-Guided Biopsies.
Lakhanpal T; Mittal BR; Kumar R; Watts A; Rana N; Singh H
Indian J Nucl Med; 2018; 33(3):209-213. PubMed ID: 29962716
[TBL] [Abstract][Full Text] [Related]
10. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic reference levels for
Alkhybari EM; McEntee MF; Brennan PC; Willowson KP; Kench PL
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):291-299. PubMed ID: 30770654
[TBL] [Abstract][Full Text] [Related]
12. Radiation Dose from Whole-Body F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Nationwide Survey in Korea.
Kwon HW; Kim JP; Lee HJ; Paeng JC; Lee JS; Cheon GJ; Lee DS; Chung JK; Kang KW
J Korean Med Sci; 2016 Feb; 31 Suppl 1(Suppl 1):S69-74. PubMed ID: 26908992
[TBL] [Abstract][Full Text] [Related]
13. Safety and Diagnostic Yield of
Kumar R; Singh SK; Mittal BR; Vadi SK; Kakkar N; Singh H; Krishnaraju VS; Kumar S; Bhattacharya A
Radiology; 2022 May; 303(2):392-398. PubMed ID: 35191735
[TBL] [Abstract][Full Text] [Related]
14. Estimation of radiation dosimetry for
Green MA; Eitel JA; Fletcher JW; Mathias CJ; Tann MA; Gardner T; Koch MO; Territo W; Polson H; Hutchins GD
Nucl Med Biol; 2017 Mar; 46():32-35. PubMed ID: 28012435
[TBL] [Abstract][Full Text] [Related]
15. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.
Lütje S; Gomez B; Cohnen J; Umutlu L; Gotthardt M; Poeppel TD; Bockisch A; Rosenbaum-Krumme S
Clin Nucl Med; 2017 Jan; 42(1):20-25. PubMed ID: 27846003
[TBL] [Abstract][Full Text] [Related]
16. Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mondal A; Mishra AK; Dwarakanath BS
Indian J Med Res; 2015 Dec; 142(6):721-31. PubMed ID: 26831421
[TBL] [Abstract][Full Text] [Related]
17. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
Willowson KP; Bailey EA; Bailey DL
Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
[TBL] [Abstract][Full Text] [Related]
18. Re-Evaluation of Patient-Sourced Radiation Doses in PET/CT.
Şenışık AM; Kökkülünk HT; Yüksel M
Curr Radiopharm; 2023; 16(2):163-169. PubMed ID: 36593536
[TBL] [Abstract][Full Text] [Related]
19. [
Green MA; Hutchins GD; Bahler CD; Tann M; Mathias CJ; Territo W; Sims J; Polson H; Alexoff D; Eckelman WC; Kung HF; Fletcher JW
Mol Imaging Biol; 2020 Jun; 22(3):752-763. PubMed ID: 31429050
[TBL] [Abstract][Full Text] [Related]
20. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
